Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;24(11):1813-1824.
doi: 10.1038/s41590-023-01634-7. Epub 2023 Oct 9.

The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity

Affiliations

The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity

Jie Li et al. Nat Immunol. 2023 Nov.

Abstract

Kupffer cells, the liver tissue resident macrophages, are critical in the detection and clearance of cancer cells. However, the molecular mechanisms underlying their detection and phagocytosis of cancer cells are still unclear. Using in vivo genome-wide CRISPR-Cas9 knockout screening, we found that the cell-surface transmembrane protein ERMAP expressed on various cancer cells signaled to activate phagocytosis in Kupffer cells and to control of liver metastasis. ERMAP interacted with β-galactoside binding lectin galectin-9 expressed on the surface of Kupffer cells in a manner dependent on glycosylation. Galectin-9 formed a bridging complex with ERMAP and the transmembrane receptor dectin-2, expressed on Kupffer cells, to induce the detection and phagocytosis of cancer cells by Kupffer cells. Patients with low expression of ERMAP on tumors had more liver metastases. Thus, our study identified the ERMAP-galectin-9-dectin-2 axis as an 'eat me' signal for Kupffer cells.

PubMed Disclaimer

References

    1. Darvin, P., Toor, S. M., Sasidharan Nair, V. & Elkord, E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp. Mol. Med. 50, 1–11 (2018). - DOI - PubMed
    1. Zhou, G., Boor, P. P. C., Bruno, M. J., Sprengers, D. & Kwekkeboom, J. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. Br. J. Cancer 126, 10–23 (2022). - DOI - PubMed
    1. Bae, J. et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8(+) T cells to overcome immunotherapy resistance in cancer. Nat. Cell Biol. 24, 1754–1765 (2022). - DOI - PubMed
    1. & Saadey, A. A. et al. Rebalancing TGFbeta1/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy.Nat. Immunol. 24, 280–294 (2023). - DOI - PubMed
    1. Li, M. O. et al. Innate immune cells in the tumor microenvironment. Cancer cell 39, 725–729 (2021). - DOI - PubMed